Company
Alto Neuroscience, Inc. (ANRO)
Standardized SEC financial data for Alto Neuroscience, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001999480 · NYSE · Pharmaceutical Preparations.
Return on equity
-41.8%
Free cash flow
-$51.8M
Debt / equity
0.11×
Current ratio
15.69×
EPS (diluted)
$-2.19
Income statement
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| R&D expense | $30.3M | $47.0M | $45.6M |
| SG&A expense | $7.5M | $21.6M | $20.7M |
| Operating income | -$37.8M |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $48.3M | $82.5M | $168.7M | $177.0M |
| Total current assets | — | $85.4M | $169.3M | $177.7M |
Cash flow
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$33.4M | -$47.4M | -$51.8M |
| Capital expenditures | $470K | $2.1M | $24K |
| Free cash flow | -$33.9M | -$49.5M |
Get ANRO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ANRO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ANRO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"